文献速递青光眼

管分流 versus 小梁切除术IRIS登记研究:1年二次治疗结局

Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes.
PubMed 文献 · Am J Ophthalmol · 2023-08-23

TVTIRIS是一项回顾性队列研究,利用2013-2017年IRIS登记数据比较既往小梁切除术和/或白内障术后眼行管分流或小梁切除术的1年结局。管分流组与小梁切除术组眼压均较基线显著下降且降幅相当,但小梁切除术组使用的降眼压药物更少,TVTIRIS中再次手术更多。TVTIRIS小梁切除术组与TVTRCT小梁切除术组1年眼压和药物减少相似。

要点

  • 管分流组眼压从基线26.6±6.5 mmHg降至1年14.3±4.8 mmHg,小梁切除术组从25.3±6.4 mmHg降至13.5±5.2 mmHg。
  • TVTIRIS中管分流组236眼(56.3%)、小梁切除术组183眼(43.7%),两组1年眼压降幅相当。
  • TVTIRIS中再次手术多于TVTRCT,小梁切除术组用药少于管分流组。

核心结论

  • TVTIRIS管分流组和小梁切除术组1年眼压降幅相当,但小梁切除术眼使用的降眼压药物更少。
  • TVTIRIS小梁切除术组与TVTRCT小梁切除术组1年眼压和药物减少相似。
  • 随机对照试验和电子健康记录数据均对手术结局提供宝贵信息。

研究设计与样本

  • TVTIRIS为回顾性队列研究,使用2013-2017年IRIS登记数据识别既往小梁切除术和/或白内障手术后接受管分流或小梁切除术且随访1年的眼。
  • TVTIRIS队列中管分流组236眼(56.3%),小梁切除术组183眼(43.7%)。
  • TVTRCT在相似眼中比较Baerveldt 350-mm2青光眼植入物与小梁切除术。

主要发现

  • 管分流组眼压(均值±SD)从基线26.6±6.5 mmHg降至1年14.3±4.8 mmHg。
  • 小梁切除术组眼压从基线25.3±6.4 mmHg降至1年13.5±5.2 mmHg。
  • 两项研究的小梁切除术组1年眼压降幅相似(P = .18),但TVTRCT队列在所有时间点使用的药物更少(P < .01)。
  • 两项研究的管分流组间平均眼压和药物差异更明显,推测因TVTIRIS纳入带阀管。
  • TVTIRIS中再次手术更多。

关键数值与推荐

  • TVTIRIS管分流组眼压从基线26.6±6.5 mmHg降至1年14.3±4.8 mmHg,小梁切除术组从25.3±6.4 mmHg降至13.5±5.2 mmHg。
  • 两项研究小梁切除术组1年眼压降幅比较P = .18,TVTRCT队列所有时间点用药更少P < .01。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe 1-year secondary outcomes in the Tube Versus Trabeculectomy IRIS® (Intelligent Registry In Sight) Registry Study (TVTIRIS), and to compare to the TVT randomized controlled trial (TVTRCT). DESIGN: TVTIRIS was a retrospective cohort study. METHODS: The 2013-2017 IRIS Registry was used to identify eyes that received a tube shunt (tube) or trabeculectomy after a previous trabeculectomy and/or cataract surgery and had 1 year of follow-up. The TVTRCT compared a Baerveldt 350-mm2 glaucoma implant to trabeculectomy in similar eyes. RESULTS: In the TVTIRIS cohort, the tube (n = 236, 56.3%) and trabeculectomy (n = 183, 43.7%) groups had similar and significant reductions in intraocular pressure (IOP) from baseline to 1 year. In the tube group, IOP (mean ± SD) decreased from 26.6 ± 6.5 mm Hg at baseline to 14.3 ± 4.8 mm Hg at 1 year. In the trabeculectomy group, IOP decreased from 25.3 ± 6.4 mm Hg at baseline to 13.5 ± 5.2 mm Hg at 1 year. The trabeculectomy groups from both studies had similar 1-year IOP reduction (P = .18), although the TVTRCT cohort used fewer medications at all time points (P < .01). There were more pronounced differences in the mean IOP and medications between the tube groups in the 2 studies, presumably due to the inclusion of valved tubes in TVTIRIS. More reoperations occurred in TVTIRIS. CONCLUSIONS: The TVTIRIS tube and trabeculectomy groups had comparable 1-year IOP reduction, although trabeculectomy eyes used fewer glaucoma medications. The trabeculectomy group in TVTIRIS and TVTRCT had similar IOP and medication reduction at 1 year. Randomized controlled trials and electronic health record data both provide invaluable insight into surgical outcomes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sun CQ, McSoley MJ, Lum F, et al. Tube Versus Trabeculectomy IRIS Registry Study: 1-Year Secondary Treatment Outcomes. Am J Ophthalmol. 2023. PMID: 37625509. doi:10.1016/j.ajo.2023.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。